PentaVision acquires Vision Care Group brand

Article

Springer Vision Care Group publishing management team form new company PentaVision and purchase the six Vision Care Group titles.

 

Ambler, PA-Springer Adis US LLC announced the asset purchase of its Vision Care Group of media and events by a new company formed by the Vision Care Group's publishing management team. The new company, PentaVision LLC, is based in Ambler, PA. Terms of the deal were not disclosed.

PentaVision will continue to produce all Vision Care Group conferences and electronic products, as well as the 6 magazines in its portfolio: Contact Lens Spectrum, Eyecare Business, Ophthalmology Management, Optometric Management, Ophthalmic Professional, and Retinal Physician. The PentaVision management includes Mark Durrick, Douglas Parry, Robert Verna, and Roger Zimmer, all currently operating units within the Vision Care Group at Springer. In addition, Thomas J. Wilson, will act as president of PentaVision and managing member of the LLC.

Said Wilson, a former owner of the Vision Care Group with BCI until 1999, “We feel strongly that this unique domain expertise and our entrepreneurial background will deliver an invigorated business perspective. The management group here at PentaVision is cohesive, determined, and intends to build on our legacy of jointly produced success.”

 

Read more articles from this week's News Flash.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.